Medicine and Dentistry
JC Virus
100%
Glia
57%
Granule Cell
57%
Rituximab
42%
Infection
28%
Cerebellar Ataxia
28%
Patient
28%
Clinical Syndrome
14%
Combination Therapy
14%
Diagnosis
14%
Ataxia
14%
Progressive Multifocal Leukoencephalopathy
14%
Natalizumab
14%
Viral Tropism
14%
Cerebellum Degeneration
14%
Polyomavirus Infection
14%
Assessment
14%
Inpatient
14%
Pharmacology, Toxicology and Pharmaceutical Science
JC Virus
100%
Rituximab
42%
Infection
28%
Case Report
28%
Cerebellar Ataxia
28%
Ataxia
14%
Natalizumab
14%
Progressive Multifocal Leukoencephalopathy
14%
Polyomavirus Infection
14%
Syndrome
14%
Cerebellum Degeneration
14%
Neuroscience
Granule Cell
57%
Ataxia
42%
Rituximab
42%
Progressive Multifocal Leukoencephalopathy
14%
Natalizumab
14%
Tropism
14%
INIS
patients
42%
assessments
14%
therapy
14%
mutations
14%